Molecule intelOpportunity: Moderate0

Betaxolol

9 brands · 7 companies · product forms

Opportunity snapshot

Launch attractiveness
35
Market saturation
18
Price room
81
Regulatory risk
0
9
brands
7
companies
Rs 479.1
median price
4
price points
4.23x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 22%

Price room

Across observed sources and strengths
CheapestRs 183.12
MedianRs 479.1
Most expensiveRs 775.08
Spread4.23×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.23x across 4 trusted points (Rs 183.12-775.08). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 2 live products for Betaxolol — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(81) + 20% low-competition(82) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

7 canonical companies and 9 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.23x across 4 trusted points (Rs 183.12-775.08). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.